Aethlon Medical, Inc.
AEMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $2 | $4 | $14 |
| - Cash | $6 | $3,765 | $6 | $5 |
| + Debt | $0 | $574 | $1 | $1 |
| Enterprise Value | – | -$3,189 | -$0 | $10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$2 | -$6 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$2 | -$6 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.74 | -8.5 | -40.1 | -8.6 |
| % Growth | 56% | 78.8% | -366.3% | – |
| Operating Cash Flow | -$2 | -$1,715 | -$2 | -$2 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$2 | -$1,715 | -$2 | -$2 |